AI-Powered drug Discovery Services for membrane proteins
| beta·break | noun
In bouldering: an entirely different sequence of moves to solve a climb more efficiently.
Our mission
Traditional drug discovery is slow, inefficient, outdated, costly, and often times impossible due to targets deemed undruggable.
At BetaBreak Labs, we leverage AI to accelerate lead identification of small molecules, peptides and nanobodies as drugs or diagnostic tools targeting membrane proteins. Our AI-driven approach will make the impossible possible.